Furthermore, we have identified a potential role for PDH, complex V, the complement factor C1q, and PKCδ in the pathology, paving the way for future studies of the therapeutic potential of modulating these pathways in the quest for effective treatments of mitochondrial disease. The gene discussed is PDP1; the disease is inborn mitochondrial metabolism disorder.